Search
Partnership for Safe Medicines 2011 Interchange Conference Archive Opening remarks from Scott LaGanga, PSM Executive Director [ Read blog ] [ Watch video ]Video statement from Sen. Bennett (CO) [ Watch video | Read blog ]Comments from Rep. Jim Matheson (UT) [ Read blog ] [ Watch video ] Protecting our medicines: moderated by Scott Lassman, Kleinfeld, Kaplan and Becker…
Read MoreA vaccine, developed by the PATH’s Malaria Vaccine Initiative in partnership with GlaxoSmithKline, providing approximately 50% efficacy against malaria, is the result of 25 years of research, and the bravery of scientists willing to infect themselves with the disease in order to test the vaccine.
From the Maryland Attorney General, to the International Association of Patient Organizations, the second annual Partnership for Safe Medicines Interchange 2011 provided local and international perspectives on the issues involving counterfeit medicine. The Partnership for Safe Medicines 2011 Interchange on October 27, began with dynamic remarks from Colorado Senator Michael Bennet and Congressman Jim Matheson of Utah highlighting the risks…
Read MoreDeputy Director Kumar Kibble of the U.s. Immigration and Customs Enforcement (ICE), Department of Homeland Security delivered the keynote address. Kibble started his remarks by reminding us that he is personally inspired Dr. Francses Kelsey of the FDA who blocked the use of thalidomide in the US for pregnant women in 1960, while over 10,000 children in other countries suffered serious birth defects…
Read MoreCollaboration within the U.S. government, collaboration between governments themselves, and collaboration with the private sector and, all stakeholder groups is essential to the fight against counterfeit and substandard medicines, said U.S. Under Secretary of State Robert D. Hormats during a speech today at the annual Interchange hosted today by the Partnership for Safe Medicines (PSM).
Read MoreAt the third panel, "Safe Medicines: The Role of Patients & Healthcare Professionals," Jeremiah Mwangi, Policy & External Affairs Director, International Alliance of Patients' Organizations, spoke on the role of patients. Mwangi said that counterfeit drugs are a matter of patient safety, eroding trust in healthcare systems, and creating a public health risk. IAPO has called for a global approach…
Read MoreThe second panelist, Connie Jung from the Office of Drug Security, Integrity and Recall from the U.S. Food and Drug Administration spoke about how to help patients protect themselves from counterfeit drugs. She said that patients first of all need to be aware of the risk of receiving counterfeit medications and potential problems associated with them. FDA is committed to…
Read More